AstraZeneca faced a defining moment in pharmaceutical marketing. The patent on its blockbuster drug Prilosec was expiring, and the company needed to transition its customer base to Nexium, a closely related compound, before generic competitors eroded its market position. The window was narrow, the stakes were enormous, and the campaign required both mass reach and precision targeting at a time when digital pharmaceutical marketing was largely uncharted territory.

As part of the Yahoo! strategic team, the founder of Marketing Partner Co. helped design and execute a landmark digital campaign that brought Nexium to millions of consumers online during the critical launch window. Yahoo! was the dominant digital platform of the era, and its reach made it the ideal channel to establish Nexium as a household name fast.

The strategy combined mass-reach display and content placements with targeted health category advertising, meeting consumers at the moment they were researching acid reflux and heartburn remedies. The Purple Pill identity, already being established through television and print, was reinforced and extended into digital with messaging that drove both brand recognition and prescription consideration. The campaign helped establish early digital pharmaceutical advertising as a credible, high-ROI channel.

The results during the critical launch period were exceptional. Nexium grew from $651 million in its first year on market to $1.978 billion in its second, a 204% revenue increase driven by the aggressive digital and mass-market campaign strategy the team helped execute. Nexium captured more than 20% of the US prescription market for proton pump inhibitors within two years of launch, and went on to become one of the best-selling prescription drugs in American pharmaceutical history.